A Study of Flurbiprofen 8.75 mg Lozenge in Patients With Pharyngitis
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The purposes of this study is to demonstrate the analgesic efficacy of flurbiprofen 8.75 mg
lozenge compared to its vehicle lozenge and to demonstrate the safety of the flurbiprofen
lozenge throughout the course of treating sore throat due to acute pharyngitis.